China Jo-Jo Drugstores Acquires Ridgeline International Limited
Ticker: RDGT · Form: 6-K · Filed: Feb 3, 2025 · CIK: 1856084
| Field | Detail |
|---|---|
| Company | China Jo-Jo Drugstores, Inc. (RDGT) |
| Form Type | 6-K |
| Filed Date | Feb 3, 2025 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 8 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: acquisition, foreign-private-issuer
TL;DR
China Jo-Jo Drugstores just bought Ridgeline International Limited. Details TBD.
AI Summary
China Jo-Jo Drugstores, Inc. announced on February 3, 2025, that it has acquired Ridgeline International Limited. The filing does not specify the dollar amount or exact date of the acquisition, but it was furnished under a Form 6-K report for the month of February 2025.
Why It Matters
This acquisition could expand China Jo-Jo Drugstores' market presence or service offerings, potentially impacting its future revenue and competitive position.
Risk Assessment
Risk Level: medium — The filing is a routine report and doesn't contain specific financial details about the acquisition, making it difficult to assess the immediate financial impact or associated risks.
Key Players & Entities
- China Jo-Jo Drugstores, Inc. (company) — Filer of the report and acquirer
- Ridgeline International Limited (company) — Acquired entity
- 001-40724 (company) — SEC File Number for China Jo-Jo Drugstores, Inc.
- 20250203 (date) — Filing date
FAQ
What was the purchase price for Ridgeline International Limited?
The filing does not disclose the purchase price for Ridgeline International Limited.
When exactly did the acquisition of Ridgeline International Limited close?
The filing states the acquisition occurred 'On January' but does not provide a specific day or year, only that the report is for the month of February 2025.
What is the business of Ridgeline International Limited?
The filing does not provide details on the business operations of Ridgeline International Limited.
What is the strategic rationale behind acquiring Ridgeline International Limited?
The filing does not explain the strategic reasons for the acquisition.
Will this acquisition impact China Jo-Jo Drugstores' financial outlook for the current fiscal year?
The filing does not provide information to assess the impact on the company's financial outlook.
Filing Stats: 2,050 words · 8 min read · ~7 pages · Grade level 18.3 · Accepted 2025-02-03 08:30:06
Filing Documents
- ea0229549-6k_chinajojo.htm (6-K) — 39KB
- ea022954901ex10-1_china.htm (EX-10.1) — 410KB
- ea022954901ex10-2_china.htm (EX-10.2) — 135KB
- ea022954901ex99-1_china.htm (EX-99.1) — 17KB
- 0001213900-25-009126.txt ( ) — 602KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: February 3, 2025 CHINA JO-JO DRUGSTORES, INC. By: /s/ Lei Liu Name: Lei Liu Title: Chief Executive Officer 5